| | 
Part, Chapter, Paragraph
1501 III, 10. 5. 1 | Available at: htt ~ ~Takano T, et al (2002): Urban residential
1502 III, 10. 5. 1 | 126-136.~ ~Vandentorren S et al, (2007): August 2003
1503 III, 10. 5. 1 | at: htt ~ ~Wilkinson P, et al (2007): Energy, energy
1504 III, 10. 5. 1 | 9593): 1175-87~ ~Wright AJ, et al (2005): Dwelling temperatures
1505 III, 10. 5. 2 | are defined (Johnson-Webb et al., 1997), and needs to
1506 III, 10. 5. 2 | to urban areas (O`Reilly et al., 2007).~ ~Table 10.5.
1507 III, 10. 5. 2 | long-standing illnesses, Lopez-Abuin et al. (2005) state that in
1508 III, 10. 5. 2 | overweight cases (Verheij et al., 1998). This result
1509 III, 10. 5. 2 | of urban places (Powles et al, 2002).~ ~Within Germany,
1510 III, 10. 5. 2 | urban settings (Du Prel et al., 2006). A UK-study shows
1511 III, 10. 5. 2 | hospitalization (Gulliford et al, 2004).~For asthma, data
1512 III, 10. 5. 2 | rural settings (11.7%) (Roel et al., 2005).~ ~For Scotland,
1513 III, 10. 5. 2 | diagnosed at all (Campbell et al., 2000). Research has
1514 III, 10. 5. 2 | and thrombolysis (Rawles et al, 1998), often because
1515 III, 10. 5. 2 | a causal factor (Paykel et al., 2000). In comparison,
1516 III, 10. 5. 2 | be urban dwellers (Völzke et al., 2006). Other behavioral
1517 III, 10. 5. 2 | Dutch survey (Van Bergen et al., 2006) brought about
1518 III, 10. 5. 2 | medical services.~Lopez-Abuin et al. (2005) have listed the
1519 III, 10. 5. 2 | January 2008) ~Campbell NC et al. (2000): Rural factors
1520 III, 10. 5. 2 | Office Limited.~ ~Du Prel, X et al. (2006): Preschool children'
1521 III, 10. 5. 2 | Luxembourg.~ ~Gulliford MC et al. (2004): Availability
1522 III, 10. 5. 2 | held by Jouke van der Zee et al. (Netherlands Institute
1523 III, 10. 5. 2 | 30:269-280.~ ~Powles, J et al. (2002): Stroke in urban
1524 III, 10. 5. 2 | 2 August 2007).~ ~Roel E et al. (2005): Clinically diagnosed
1525 III, 10. 5. 2 | September 2007)~ ~Rawles J et al. (1998): Call to needle
1526 III, 10. 5. 2 | 576-8.~ ~Van Bergen JEAM et al. (2006): Prevalence of
1527 III, 10. 5. 2 | 56: 104–109.~ ~Verheij RA et al. (1998): Urban-rural
1528 III, 10. 5. 2 | Health 52:487-493.~ ~Völzke H et al. (2006): Urban-rural
1529 III, 10. 5. 3 | 29 billion) in 2003 (Leal et al, 2005). According to
1530 III, 10. 5. 3 | billion (Andlin-Sobocki et al, 2005). These are primarily
1531 III, 10. 6. 1 | compared to men (Kessler et al., 1985).~ ~The significance
1532 III, 10. 6. 1 | known risk factors (Kaplan et al., 1988). The quality
1533 III, 10. 6. 1 | heart disease (De Vogli et al., 2007). A longitudinal
1534 III, 10. 6. 1 | parental stress (Saisto et al., 2008).~ ~Social network
1535 III, 10. 6. 1 | performed in 2001 (Korkeila et al., 2003), measured social
1536 III, 10. 6. 1 | activities (Börsch-Supan et al., 2005). The first wave
1537 III, 10. 6. 1 | or less of cases (Kohb et al., 2005).~ ~The HBSC study
1538 III, 10. 6. 1 | family connectedness (Currie et al., 2008).~ ~In general,
1539 III, 10. 6. 1 | easy communication (Currie et al., 2008).~ ~Figure 10.
1540 III, 10. 6. 1 | gender than girls (Currie et al., 2008).~ ~Figure 10.
1541 III, 10. 6. 1 | girls only 33%. (Currie et al., 2008).~ ~To conclude,
1542 III, 10. 6. 1 | victimization (Van Dijk et al, 2005).~ ~Figure 10.6.
1543 III, 10. 6. 1 | customs may be kept) (Austin et al, 2002).~ ~Overall, people
1544 III, 10. 6. 1 | perceived as safe (Shenassa et al, 2006). Street lighting,
1545 III, 10. 6. 1 | residents at night-time (Carter et al, 2003).~ ~
1546 III, 10. 6. 1 | References~ ~Austin DM, et al (2002): The effects of
1547 III, 10. 6. 1 | Available at http ~ ~Carter SP, et al, (2003): Zoning out crime
1548 III, 10. 6. 1 | applications. Editors Sarason et Sarason. Martinus Nijhoff
1549 IV, 11. 1. 1 | the past century (Bunker et al, 1994). At the same time,
1550 IV, 11. 1. 3 | in Europe (e.g. Rutstein et al, 1976; Mackenbach et
1551 IV, 11. 1. 3 | et al, 1976; Mackenbach et al, 1990; Holland et al,
1552 IV, 11. 1. 3 | Mackenbach et al, 1990; Holland et al, 1994; Westerling, 1996).
1553 IV, 11. 1. 3 | government authorities (Preker et al, 2002).~ ~While the past
1554 IV, 11. 1. 3 | performance (Retzlaff-Roberts et al, 2004; Social and Cultural
1555 IV, 11. 1. 3 | component measures (Naylor et al, 2002). While rankings
1556 IV, 11. 1. 4 | seeking care (Gulliford et al 2002).~ ~Access to care
1557 IV, 11. 1. 4 | seek health care (Gulliford et al 2002). Educational attainment,
1558 IV, 11. 1. 4 | countries (van Doorslaer et al, 2004). Based on the
1559 IV, 11. 1. 4 | of visits) (van Doorslaer et al, 2004). Portugal also
1560 IV, 11. 1. 4 | other countries) (Masseria et al 2004). A recent study
1561 IV, 11. 1. 4 | found in dental care (Allin et al 2008).~ ~Another important
1562 IV, 11. 1. 4 | treatment or utilization (Mooney et al, 1991; Culyer et al,
1563 IV, 11. 1. 4 | Mooney et al, 1991; Culyer et al, 1992; Mooney et al,
1564 IV, 11. 1. 4 | Culyer et al, 1992; Mooney et al, 1992) (Goddard and Smith
1565 IV, 11. 1. 5 | been unsuccessful) (Brook et al, 2000). Moreover, due
1566 IV, 11. 1. 5 | Blumenthal, 1996; Brook et al, 1996; Evans et al, 2001;
1567 IV, 11. 1. 5 | Brook et al, 1996; Evans et al, 2001; Shaw and Kalo,
1568 IV, 11. 1. 5 | improve quality (Marshall et al, 2003). There are several
1569 IV, 11. 1. 5 | negotiating contracts (Goldfarb et al, 2003; Epstein et al,
1570 IV, 11. 1. 5 | Goldfarb et al, 2003; Epstein et al, 2004; Mainz et al, 2004).
1571 IV, 11. 1. 5 | Epstein et al, 2004; Mainz et al, 2004). Observational
1572 IV, 11. 1. 5 | health system (Mattke, Kelley et al, 2006). Among the indicators
1573 IV, 11. 1. 5 | populations (Mattke, Kelley et al, 2006).~ ~In addition,
1574 IV, 11. 1. 5 | funded AGREE project (Burgers et al, 2004). While some countries
1575 IV, 11. 1. 5 | prescribing behaviour (Hetlevik et al, 2000), others suggest
1576 IV, 11. 1. 5 | Lancaster, 2000; Perleth et al, 2001). While most guidelines
1577 IV, 11. 1. 5 | legal implications (Carter et al, 1995; Cheah, 1998).
1578 IV, 11. 1. 5 | being delivered (Durieux et al, 2000).~ ~Regulating
1579 IV, 11. 1. 5 | prescribing suitability (Mossialos et al, 2004). In the UK, prescribing
1580 IV, 11. 1. 5 | by clinicians (Taggiasco et al, 1992).~ ~Provider payment
1581 IV, 11. 1. 5 | outcome data (Mossialos et al, 2007).~ ~There are a
1582 IV, 11. 1. 5 | healthcare quality (Rosenthal et al, 2004; Campbell, Reves
1583 IV, 11. 1. 5 | al, 2004; Campbell, Reves et al, 2007).~ ~There is inconclusive
1584 IV, 11. 1. 5 | disease management (Spooner et al, 2001), and may have
1585 IV, 11. 1. 5 | bureaucratic schemes (Mossialos et al 2007). Thus, it would
1586 IV, 11. 1. 5 | expected to use them (Claridge et al, 2006).~ ~Encouraging
1587 IV, 11. 1. 5 | adverse events (81.8%) (Wilson et al, 1995). Less research
1588 IV, 11. 1. 5 | be prevented (Mossialos et al, 2007).~ ~In the US,
1589 IV, 11. 1. 5 | family physicians (Dovey et al, 2003), while another,
1590 IV, 11. 1. 5 | seriously harmful (Lesar et al, 1997). Preventable adverse
1591 IV, 11. 1. 5 | longer than they should (Kohn et al, 2000). UK studies show
1592 IV, 11. 1. 5 | medical error risks (Weingart et al, 2000). Medical errors
1593 IV, 11. 1. 5 | payment systems, etc. (Dovey et al, 2002). Not just technical
1594 IV, 11. 1. 5 | delivery processes (Kohn et al, 2000). Without robust
1595 IV, 11. 1. 5 | disability levels (Kohn et al, 2000).~ ~A cross-country
1596 IV, 11. 1. 6 | utilization rates (Figueras et al, 2004). Others have attempted
1597 IV, 11. 1. 6 | caution (Retzlaff-Roberts et al, 2004; Starfield et al,
1598 IV, 11. 1. 6 | Retzlaff-Roberts et al, 2004; Starfield et al, 2005). Moreover, these
1599 IV, 11. 1. 6 | by specialists (Krasnik et al. 1990).~ ~Across Europe,
1600 IV, 11. 1. 6 | behaviour (Chaix-Couturier et al, 2000; Gosden et al,
1601 IV, 11. 1. 6 | Chaix-Couturier et al, 2000; Gosden et al, 2006). Therefore, more
1602 IV, 11. 1. 6 | relationships (Robinson et al, 2004).~ ~Most European
1603 IV, 11. 1. 6 | methodologically sound system (Busse et al, 2006). Technical challenges
1604 IV, 11. 1. 6 | higher paying DRG (Busse et al, 2006).~ ~DRGs are used
1605 IV, 11. 1. 6 | Federation, 2006; Schreyogg et al, 2006). Although the
1606 IV, 11. 1. 6 | high cost patients (Busse et al, 2006). A common incentive
1607 IV, 11. 1. 6 | a treatment group (Busse et al, 2006).~ ~In the light
1608 IV, 11. 1. 6 | and Austria) (Schreyogg et al, 2006). Reimbursement
1609 IV, 11. 1. 6 | country’s hospitals (Schreyogg et al, 2006). Calculating reimbursement
1610 IV, 11. 1. 6 | of Luxembourg (Figueras et al, 2004). In spite of this,
1611 IV, 11. 1. 6 | within the country (Thomson et al, 2004).~ ~Private health
1612 IV, 11. 2. 1 | accessible to the public (Ettelt et al, 2006). This trend is
1613 IV, 11. 2. 1 | equity and efficiency (Ettelt et al, 2006).~ ~Studies have
1614 IV, 11. 2. 1 | health outcomes (Macinko et al, 2003). Using OECD data,
1615 IV, 11. 2. 1 | specialist physicians (Starfield et al, 2005).~ ~Variations
1616 IV, 11. 2. 1 | discussed elsewhere (Figueras et al, 2004), and below.~ ~
1617 IV, 11. 2. 1 | Scotland and Germany (Castoro et al, 2007).~ ~It is also
1618 IV, 11. 2. 1 | admission rates (Mattke et al 2007). As the experience
1619 IV, 11. 2. 2 | in the Netherlands (Judge et al 2006). The concept of
1620 IV, 11. 2. 2 | informal processes (Allin et al 2004).~ ~Spending on
1621 IV, 11. 2. 2 | in CEE countries (McDaid et al, 2005).~ ~A common limitation
1622 IV, 11. 2. 2 | inform policy makers (Kelly et al, 2005). One of the exceptions
1623 IV, 11. 3. 1 | health care personnel (Rechel et al 2006).~ ~
1624 IV, 11. 3. 2 | short-term basis (Mossialos et al, 2006).~ ~Profit control
1625 IV, 11. 3. 2 | encourage innovation (Mossialos et al, 2006).~ ~Reimbursement
1626 IV, 11. 3. 2 | Netherlands and Sweden (Mossialos et al, 2006).~ ~The substitution
1627 IV, 11. 3. 2 | assurance mechanisms (Mossialos et al, 2005).~ ~Data and information
1628 IV, 11. 4 | in an HTA project (Busse et al., 2002). The EU funded
1629 IV, 11. 4 | assessment~ ~ ~Source: Busse et al (2002)~ ~ ~The reporting
1630 IV, 11. 6. 1 | 1984; Barer 1987; McGrail et al, 2000). There are also
1631 IV, 11. 6. 2 | tax-deductible (Van Doorslaer et al, 1999). In contrast,
1632 IV, 11. 6. 2 | health policies (Mossialos et al, 2000).~ ~Countries that
1633 IV, 11. 6. 2 | economic reasons (Preker et al. 2002). In many of these
1634 IV, 11. 6. 2 | the labour market (Sandier et al 2004). Since then, employees’
1635 IV, 11. 6. 2 | insurance (van Doorslaer et al, 2004; Mossialos and
1636 IV, 11. 6. 2 | Thomson, 2004) (Thomson et al 2008). Indeed, complementary
1637 IV, 11. 6. 2 | private market (Thomson et al 2008).~ ~There are tax
1638 IV, 11. 6. 2 | Insurance Premium Tax (Foubister et al 2006). The distributional
1639 IV, 11. 6. 2 | allocatable efficiency (Thomson et al, 2003). A review of the
1640 IV, 11. 6. 2 | efficiency gains (Gemmill et al 2008).~ ~Out-of-pocket
1641 IV, 11. 6. 2 | inpatient care (Thomson et al, 2003), and in Germany
1642 IV, 11. 6. 2 | 600 in Finland (Jemiai et al, 2004). Exemptions can
1643 IV, 11. 6. 2 | patients) and Belgium (Thomson et al, 2003). Prescription
1644 IV, 11. 6. 2 | payments in the 1990s (Preker et al, 2002). Data on out-of-pocket
1645 IV, 11. 6. 3 | most progressive (Wagstaff et al, 1999). The study also
1646 IV, 11. 6. 3 | Switzerland and the US (Wagstaff et al, 1999).~ ~Within social
1647 IV, 11. 6. 3 | be regressive (Wagstaff et al, 1999). Conversely, in
1648 IV, 11. 6. 3 | predominantly public (Wagstaff et al, 1999). Importantly,
1649 IV, 11. 6. 3 | Portugal and the UK (Wagstaff et al, 1999). Some argue that
1650 IV, 11. 6. 3 | comparisons between the Wagstaff et al and WHO studies cannot
1651 IV, 11. 6. 4 | reimbursement) (Robinson et al, 2005). See section 11.
1652 IV, 11. 6. 4 | Eastern Europe (Thomson et al 2004). Even in the countries
1653 IV, 11. 6. 4 | selection activities (van de Ven et al, 2003). Even if the risk-adjustment
1654 IV, 11. 6. 4 | insurance funds (van de Ven et al 2007).~ ~Table 11.14.
1655 IV, 11. 6. 4 | Cotisations de Sécurité et d’Allocations Familiales
1656 IV, 11. 6. 4 | Smith 2002; HiTs; Thomson et al 2004~* As communicated
1657 IV, 11. 6. 4 | disproportionately (Thomson et al, 2004). There are also
1658 IV, 11. 6. 4 | over the 1990s (Thomson et al, 2004).~ ~Historically,
1659 IV, 11. 6. 4 | cost-sharing (Schreyögg et al, 2005). With regards
1660 IV, 11. 6. 4 | or guidelines (Schreyögg et al, 2005).~ ~In many countries,
1661 IV, 11. 6. 4 | State for Health (Schreyögg et a.. 2005).~ ~In recent years,
1662 IV, 11. 6. 4 | insurance systems (Gibis et al, 2004). While there is
1663 IV, 11. 6. 4 | Germany and Switzerland (Gibis et al, 2004). All countries
1664 IV, 11. 6. 4 | and the Netherlands (Gibis et al, 2004). Unlike social
1665 IV, 11. 6. 4 | benefit levels (Thomson et al, 2004).~ ~Health technology
1666 IV, 11. 6. 4 | assessment required (Zentner et al, 2005). For example,
1667 IV, 11. 6. 4 | clinical practice (Hutton et al, 2006). The heterogeneity
1668 IV, 11. 6. 4 | production of guidance (Sorenson et al, 2007), an explicitly-defined
1669 IV, 11. 6. 5 | 16.~ ~Brook R, McGlynn E et al. (1996): "Quality of
1670 IV, 11. 6. 5 | Brook RH, McGlynn EA et al. (2000): "Defining and
1671 IV, 11. 6. 5 | 295.~ ~Bunker J, Frazier H et al. (1994): "Improving health:
1672 IV, 11. 6. 5 | Burgers JS, Fervers B et al. (2004): "International
1673 IV, 11. 6. 5 | Busse R, Schreyogg J et al. (2006): "Editorial:
1674 IV, 11. 6. 5 | Carter AO, Battista RN et al. (1995): "Proceedings
1675 IV, 11. 6. 5 | Castoro C, Bertinato L et al. (2007): Day surgery:
1676 IV, 11. 6. 5 | Chaix-Couturier C, Durand-Zaleski I et al. (2000): "Effects of
1677 IV, 11. 6. 5 | Claridge T, Parker D et al. (2006): Pathways to
1678 IV, 11. 6. 5 | Culyer AJ, Doorslaer E et al. (1992): "Comment: Utilization
1679 IV, 11. 6. 5 | 98.~ ~Dovey SM, Meyers DS et al. (2002): "A preliminary
1680 IV, 11. 6. 5 | Dovey SM, Phillips RL et al. (2003): "Types of medical
1681 IV, 11. 6. 5 | Durieux P, Chaix-Couturier C et al. (2000): "From clinical
1682 IV, 11. 6. 5 | 74.~ ~Epstein AM, Lee TH et al. (2004): "Paying Physicians
1683 IV, 11. 6. 5 | University.~ ~Ettelt S, Nolte E et al. (2006): Health care
1684 IV, 11. 6. 5 | htm.~ ~Evans D, Edejer T et al. (2001): "Measuring quality:
1685 IV, 11. 6. 5 | Figueras J, Saltman RB et al. (2004): Patterns and
1686 IV, 11. 6. 5 | Gemmill M, Thomson S et al. (forthcoming): "A literature
1687 IV, 11. 6. 5 | Gibis B, Koch-Wulkan PW et al. (2004): Shifting criteria
1688 IV, 11. 6. 5 | 1162.~ ~Goldfarb NI, Maio V et al. (2003): How Does Quality
1689 IV, 11. 6. 5 | 2007.~ ~Gosden T, Forland F et al. (2006): Cochrane Review:
1690 IV, 11. 6. 5 | Hetlevik I, Holmen J et al. (2000): "Implementing
1691 IV, 11. 6. 5 | Holland WW, Fitzgerald AP et al. (1994): “Heaven can
1692 IV, 11. 6. 5 | Holland WW, Stewart S et al. (2006): Screening in
1693 IV, 11. 6. 5 | Press.~ ~Hutton J, McGrath C et al. (2006): "Framework for
1694 IV, 11. 6. 5 | Pantheon~ ~Jemiai N, Thomson S et al. (2004): An overview
1695 IV, 11. 6. 5 | OECD.~ ~Kelly MP, McDaid D et al. (2005): Economic appraisal
1696 IV, 11. 6. 5 | Kohn LT, Corrigan JM et al., Eds. (2000): To Err
1697 IV, 11. 6. 5 | Krasnik A, Groenewegen PP et al. (1990): "Changing remuneration
1698 IV, 11. 6. 5 | Lesar TS, Briceland L et al. (1997): "Factors Related
1699 IV, 11. 6. 5 | Macinko J, Starfield B et al. (2003): "The contribution
1700 IV, 11. 6. 5 | Mackenbach JP, Bouvier-Colle MH et al. (1990): “Avoidable”
1701 IV, 11. 6. 5 | 79-80.~ ~Mainz J, Krog BR et al. (2004): "Nationwide
1702 IV, 11. 6. 5 | Marshall MN, Shekelle PG et al. (2003): "Public reporting
1703 IV, 11. 6. 5 | Masseria C, Koolman X et al. (2004): Income-related
1704 IV, 11. 6. 5 | Fund.~ ~McDaid D, Knapp M et al. (2005): Mental health
1705 IV, 11. 6. 5 | Organization.~ ~McGrail K, Green B et al. (2000): "Age, costs
1706 IV, 11. 6. 5 | Sport.~ ~ ~Mooney G, HallJ et al. (1991): "Utilisation
1707 IV, 11. 6. 5 | 480.~ ~Mooney G, Hall J et al. (1992): "Reweighing
1708 IV, 11. 6. 5 | Mossialos E, Brogan D et al. (2006): "Pharmaceutical
1709 IV, 11. 6. 5 | Mossialos E, Merkur S et al. (2006): Incentives and
1710 IV, 11. 6. 5 | Mossialos E, Dixon A et al. (2000): "Paying for
1711 IV, 11. 6. 5 | Mossialos E, Mrazek M et al. (2004): Regulating pharmaceuticals
1712 IV, 11. 6. 5 | Mossialos E, Walley T et al. (2004): Regulating pharmaceuticals
1713 IV, 11. 6. 5 | Mossialos E, Walley T et al. (2005): "Provider incentives
1714 IV, 11. 6. 5 | 1601.~ ~Naylor CD, Iron K et al. (2002): Measuring health
1715 IV, 11. 6. 5 | Perleth M, Jakubowski E et al. (2001): "What is 'best
1716 IV, 11. 6. 5 | Preker AS, Jakab M et al. (2002): Health financing
1717 IV, 11. 6. 5 | Retzlaff-Roberts D, Chang CF et al. (2004): "Technical efficiency
1718 IV, 11. 6. 5 | Robinson JC, Shortell SM et al. (2004): "The Alignment
1719 IV, 11. 6. 5 | Robinson R, Jakubowski E et al. (2005): Organization
1720 IV, 11. 6. 5 | Rosenthal MB, Fernandopulle R et al. (2004): "Paying for
1721 IV, 11. 6. 5 | Rutstein DD, Berenberg W et al, (1976): “Measuring the
1722 IV, 11. 6. 5 | Schreyogg J, Stargardt T et al. (2006): "Methods to
1723 IV, 11. 6. 5 | Schreyögg J, Stargardt T et al. (2005): "Defining the "
1724 IV, 11. 6. 5 | Sorenson C, Kanavos P et al. (2007): Ensuring value
1725 IV, 11. 6. 5 | Spooner A, Chapple A et al. (2001): "What makes
1726 IV, 11. 6. 5 | 50.~ ~Starfield B, Shi L et al. (2005): "The Effects
1727 IV, 11. 6. 5 | Taggiasco Nì, Sarrut B et al. (1992): "European survey
1728 IV, 11. 6. 5 | Thomson S, Mossialos E et al. (2003): Cost sharing
1729 IV, 11. 6. 5 | Thomson S, Mossialos E et al. (2004): Health and health
1730 IV, 11. 6. 5 | van de Ven W, Beck K et al. (2003). "Risk adjustment
1731 IV, 11. 6. 5 | van Doorslaer E, Koolman X et al. (2004): "Explaining
1732 IV, 11. 6. 5 | Doorslaer E, Masseria C et al. (2004): Income-related
1733 IV, 11. 6. 5 | Doorslaer E, Wagstaff A et al. (1999): "The redistributive
1734 IV, 11. 6. 5 | Wagstaff A, van Doorslaer E et al., Eds. (1999): Equity
1735 IV, 11. 6. 5 | Weingart SN, Wilson RM et al. (2000): "Epidemiology
1736 IV, 11. 6. 5 | Wilson RM, Runciman WB et al., (1995): "The quality
1737 IV, 11. 6. 5 | Zentner A, Valasco-Garrido M et al., (2005): "Methods for
1738 IV, 12. 2 | vehicle-related injuries (Ditter et al, 2005). However, although
1739 IV, 12. 10 | Virksomheder, der ønsker et arbejdsmiljøcertifikat efter
1740 IV, 12. 10 | nutrition programs 2001-2005 et 2006-2010 http ~ ~Physical activity~
1741 IV, 13. 2. 3 | Netherlands.~ ~Source: Van Kreil et al (2006)~ ~DALYs lost~DIET~ ~
1742 IV, 13. 6. 1 | and Köhler, 2002; Rigby et al, 2003), in children the
1743 IV, 13. 8 | who may be affected (Stahl et al 2006). The involvement
1744 IV, 13. 9 | Hoorn S van der, Murray CJL et al (2002): Selected major
1745 IV, 13. 9 | Nations, New York.~ ~Van Kreil et al (2006) Our food, our
|
|
| |
